MENISCOCELECT
DEAD

Serial Number

77238363

Owner

Tigenix N.V.

Attorney

Thomas J. Moore

Filing Date

Jul 25, 2007

Add to watchlist:

No watchlists yet
View on USPTO

MENISCOCELECT Trademark

Serial Number: 77238363 • Registration: 3662384

MENISCOCELECT is a trademark filed by Tigenix N.V. on July 25, 2007. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Tigenix N.V. (5 trademarks)

Leuven 3001 , BE

Entity Type: 03

Trademark Details

Filing Date

July 25, 2007

Registration Date

August 4, 2009

Published for Opposition

May 19, 2009

Cancellation Date

March 11, 2016

Goods & Services

Antibodies for medical diagnostic use, for the purpose of expansion, selection, quality control and implantation of human, in vivo, cartilage forming cells including stem cell preparations of stem cell implants; pharmaceutical, veterinary or medical preparations for expansion, selection, quality control and implantation of human, in vivo, cartilage forming cells; nutritious media and growth substrates for expansion, selection, quality control and implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants; medical preparations, namely, polymer preparations and cell matrices of any type of origin for expansion, selection, medical quality control and implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants; test products for medical use, for the purpose of the control of expansion, selection, and implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants, namely, chondrocytes, chondrocyte progenitors, chondrocyte precursors and stem cells with chondrogenic properties; hormones for the promoting of the growth of cells called growth factors for medical use; veterinary or medical kits for expansion, selection, quality control and implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants, namely, kits primarily composed of growth and differentiating promoting polypeptides; quality control kits consisting primarily of monoclonal antibodies for use in disease testing and ligands or oligonucleotide primers and DNA chips for medical or veterinary use; quality control kits consisting primarily of antibodies or oligonucleotide primers and DNA chips for selection and quality control of human, in vivo, cartilage forming cells including stem cell preparations and stem cell implants for medical/diagnostic use; implementation kits consisting primarily of live cartilage forming cells

Enzymes for scientific research and development in the medical field; antibodies for medical laboratory use, for the purpose of expansion, selection, quality control and implantation of human, in vivo, cartilage forming cells including stem cell preparations of stem cell implants; quality control kits consisting primarily of monoclonal antibodies for use in disease testing and ligands or oligonucleotide primers and DNA chips for scientific or research use; quality control kits consisting primarily of antibodies or oligonucleotide primers and DNA chips for selection and quality control of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants for research/scientific use

Pharmaceutical, veterinary or medical services, namely, medical and pharmaceutical consultation and veterinary services

Veterinary or medical devices and instruments for expansion, selection, quality control and implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants, namely, kits comprised of temperature probes and injectors, stitching or gluing material for covering implantation devices for human in vivo, cartilage forming cells; medical devices and instrument kits, namely, biopsy instruments, implantation kits including medical syringes, tongs and pliers; quality control kits consisting primarily of DNA chips for medical use including expansion, selection, quality control and implantation of human, in vivo, cartilage forming cells including stem cell preparations and stem cell implants

Scientific research, development and study related to expansion, selection, quality control and implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants; quality control for others as related in human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants; custom design, development and performance of biochemical assays for the purpose of quality control of expanded or implanted human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants; scientific research, development and study related to the use of polymer membranes or cell matrices of any type of origin for expansion, selection, quality control and implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants

Filing History

CANCELLED SEC. 8 (6-YR)
Mar 11, 2016 C8..
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 23, 2014 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 23, 2014 COAR
REGISTERED-PRINCIPAL REGISTER
Aug 4, 2009 R.PR
PUBLISHED FOR OPPOSITION
May 19, 2009 PUBO
NOTICE OF PUBLICATION
Apr 29, 2009 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 13, 2009 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 9, 2009 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 9, 2009 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 9, 2009 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 9, 2009 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Mar 5, 2009 GPRN
PRIORITY ACTION E-MAILED
Mar 5, 2009 GPRA
PRIORITY ACTION WRITTEN
Mar 5, 2009 CPRA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Feb 9, 2009 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jan 16, 2009 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 8, 2009 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 20, 2008 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 19, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 19, 2008 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 19, 2008 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 21, 2008 GNRN
NON-FINAL ACTION E-MAILED
Jun 21, 2008 GNRT
NON-FINAL ACTION WRITTEN
Jun 21, 2008 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jun 13, 2008 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jun 2, 2008 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 22, 2008 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
May 22, 2008 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 1, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 1, 2008 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 30, 2008 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 31, 2007 GNRN
NON-FINAL ACTION E-MAILED
Oct 31, 2007 GNRT
NON-FINAL ACTION WRITTEN
Oct 31, 2007 CNRT
ASSIGNED TO EXAMINER
Oct 30, 2007 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Oct 25, 2007 AMPX
ASSIGNED TO LIE
Oct 18, 2007 ALIE
PAPER RECEIVED
Sep 13, 2007 MAIL
NEW APPLICATION ENTERED
Jul 30, 2007 NWAP